Related Experiment Video
Updated: Apr 17, 2026

Mutagenesis and Analysis of Genetic Mutations in the GC-rich KISS1 Receptor Sequence Identified in Humans with Reproductive Disorders
Published on: September 4, 2011
Expression and mutational analysis of Cip/Kip family in early glottic cancer
1Nano-Bio Regenerative Medical Institute, Hallym University,Chuncheon,South Korea.
Background:
Genetic alteration of cyclin-dependent kinase inhibitors has been associated with carcinogenesis mechanisms in various organs.
Objective:
This study aimed to evaluate the expression and mutational analysis of Cip/Kip family cyclin-dependent kinase inhibitors (p21CIP1/WAF1, p27KIP1 and p57KIP2) in early glottic cancer.
Methods:
Expressions of Cip/Kip family and p53 were determined by quantitative reverse transcription polymerase chain reaction and densitometry. For the analysis of p21 inactivation, sequence alteration was assessed using single-strand conformational polymorphism polymerase chain reaction. Additionally, the inactivation mechanism of p27 and p57 were investigated using DNA methylation analysis.
Results:
Reduced expression of p27 and p57 were detected in all samples, whereas the expression of p21 was incompletely down-regulated in 6 of 11 samples. Additionally, single-strand conformational polymorphism polymerase chain reaction analysis showed the p53 mutation at exon 6. Methylation of p27 and p57 was detected by DNA methylation assay.
Conclusion:
Our results suggest that the Cip/Kip family may have a role as a molecular mechanism of carcinogenesis in early glottic cancer.
Insights
The Cip/Kip family of cyclin-dependent kinase inhibitors may play a role in early glottic cancer development. Reduced expression and genetic alterations in p21, p27, and p57 were observed, suggesting their involvement in carcinogenesis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Genetic alterations in cyclin-dependent kinase inhibitors are linked to cancer development.
- The Cip/Kip family, including p21CIP1/WAF1, p27KIP1, and p57KIP2, are key regulators of cell cycle progression.
Purpose of the Study:
- To investigate the expression and mutational status of Cip/Kip family members in early glottic cancer.
- To explore the potential role of these inhibitors as molecular mechanisms in glottic carcinogenesis.
Main Methods:
- Quantitative reverse transcription polymerase chain reaction and densitometry for gene expression analysis.
- Single-strand conformational polymorphism polymerase chain reaction for p21 inactivation and p53 mutation detection.
- DNA methylation analysis to investigate p27 and p57 inactivation mechanisms.
Main Results:
- Reduced expression of p27KIP1 and p57KIP2 was observed in all samples.
- Incomplete down-regulation of p21CIP1/WAF1 expression occurred in 6 of 11 samples.
- p53 mutation at exon 6 and methylation of p27KIP1 and p57KIP2 were detected.
Conclusions:
- The Cip/Kip family of cyclin-dependent kinase inhibitors may function as a molecular mechanism in the development of early glottic cancer.
- Alterations in p21, p27, and p57 expression and genetics are implicated in glottic carcinogenesis.
More Related Videos
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Non-LTR Retrotransposons

